B cells in multiple sclerosis—from targeted depletion to immune reconstitution therapies
MT Cencioni, M Mattoscio, R Magliozzi… - Nature Reviews …, 2021 - nature.com
Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple
sclerosis (MS), but their precise roles are unclear. In this Review, we provide an overview of …
sclerosis (MS), but their precise roles are unclear. In this Review, we provide an overview of …
The cerebrospinal fluid in multiple sclerosis
F Deisenhammer, H Zetterberg, B Fitzner… - Frontiers in …, 2019 - frontiersin.org
Investigation of cerebrospinal fluid (CSF) in the diagnostic work-up in suspected multiple
sclerosis (MS) patients has regained attention in the latest version of the diagnostic criteria …
sclerosis (MS) patients has regained attention in the latest version of the diagnostic criteria …
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Background: To evaluate whether oligoclonal bands (OB) add information to MRI in
predicting both a second attack and development of disability in patients with clinically …
predicting both a second attack and development of disability in patients with clinically …
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
S Cepok, B Rosche, V Grummel, F Vogel, D Zhou… - Brain, 2005 - academic.oup.com
Multiple sclerosis is a chronic inflammatory and demyelinating disorder of the CNS with an
unknown aetiology. Although intrathecal immunoglobulin G (IgG) synthesis is a key feature …
unknown aetiology. Although intrathecal immunoglobulin G (IgG) synthesis is a key feature …
Neurofilaments as biomarkers in multiple sclerosis
CE Teunissen, M Khalil - Multiple sclerosis journal, 2012 - journals.sagepub.com
Neurodegeneration is the correlate of disease progression in multiple sclerosis (MS) and
thus biological biomarkers that sensitively reflect this process are much needed …
thus biological biomarkers that sensitively reflect this process are much needed …
Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review
WT Ma, C Chang, ME Gershwin, ZX Lian - Journal of autoimmunity, 2017 - Elsevier
The etiology of autoimmune diseases is due to a combination of genetic predisposition and
environmental factors that alter the expression of immune regulatory genes through various …
environmental factors that alter the expression of immune regulatory genes through various …
[HTML][HTML] Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
LM Villar, MC Sádaba, E Roldán… - The Journal of …, 2005 - Am Soc Clin Investig
Oligoclonal IgM bands restricted to cerebrospinal fluid are an unfavorable prognostic marker
in MS, the most common demyelinating disease of the CNS. We have attempted to identify …
in MS, the most common demyelinating disease of the CNS. We have attempted to identify …
Inflammasome proteins as biomarkers of multiple sclerosis
RW Keane, WD Dietrich… - Frontiers in neurology, 2018 - frontiersin.org
Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord. The
inflammasome is a multiprotein complex that contributes to the innate immune response in …
inflammasome is a multiprotein complex that contributes to the innate immune response in …
Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis
LM Villar, J Masjuan… - Annals of Neurology …, 2003 - Wiley Online Library
Intrathecal IgM synthesis (ITMS) predicts a worse evolution in the first stages of multiple
sclerosis (MS). The aim of this study was the follow‐up of a group of relapsing‐remitting MS …
sclerosis (MS). The aim of this study was the follow‐up of a group of relapsing‐remitting MS …
Body fluid biomarkers for multiple sclerosis—the long road to clinical application
CE Teunissen, A Malekzadeh, C Leurs… - Nature Reviews …, 2015 - nature.com
There is a strong unmet clinical need for objective body fluid biomarkers to assist early
diagnosis and estimate long-term prognosis, monitor treatment response and predict …
diagnosis and estimate long-term prognosis, monitor treatment response and predict …